The global pathogen detection market refers to the industry dedicated to identifying and monitoring disease-causing agents across various sectors, including healthcare, agriculture, and food safety. This market encompasses a wide range of products and technologies designed to detect pathogens, such as bacteria, viruses, and fungi. Diagnostic tools, including PCR, immunoassays, and next-generation sequencing, play a crucial role in this market, providing accurate and timely results.
Access Full Report at https://www.databridgemarketresearch.com/es/reports/global-pathogen-detection-market
Data Bridge Market Research analyses that the Global Pathogen Detection Market which was USD 4.9 billion in 2022, is expected to reach USD 9.07 billion by 2030, at a CAGR of 8% during the forecast period 2023 to 2030. Biodefense preparedness drives heightened investments in rapid, accurate pathogen detection technologies to identify potential biological threats, addressing the imperative need for proactive measures against bioterrorism. This ensures swift response capabilities, safeguarding public health and enhancing security in the face of emerging biosecurity challenges.
Key Findings of the Study
Increasing incidence of infectious diseases is expected to drive the market's growth rate
The escalating global incidence of infectious diseases underscores the imperative for robust pathogen detection methods. This heightened demand stems from the pressing need to facilitate early diagnosis and prompt intervention. As diseases proliferate, there's a crucial emphasis on advanced detection technologies to swiftly identify pathogens. This proactive approach not only aids in containment but also enhances overall public health outcomes by enabling timely and targeted responses to emerging infectious threats on a worldwide scale.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Products, Services), Consistency (Solid Media, Liquid Media), Culture Media (Chemical Composition, Synthetic Media), Contaminant Type (Salmonella, E. Coli, Listeria, Campylobacter, Clostridium Perfringens, Pseudomonas, Cronobacter, Coliforms, Legionella, Others), Total Count (Spoiling Organisms, Yeast and Moulds, Others), Technology (Rapid, Traditional, Other Molecular-Based Tests), Customer Type (Service Lab, Industry, Governmental/Non-Profit Organization), Application (Diagnostics, Pathology, Forensics, Clinical Research, Drug Discovery), End User (Pathology Laboratories, Diagnostic Centers, Hospitals, Biotechnology Companies, Pharmaceutical Companies, Culture Collection Repositories, Cooling Towers, Blood Banks, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BIOMÉRIEUX (France), Agilent Technologies, Inc. (U.S.), BD (U.S.), biotools (U.S.), SGS Société Générale de Surveillance SA (Switzerland), Bureau Veritas (India) Private Limited (India), Intertek Group plc (U.K.), Eurofins Scientific (Luxembourg), Mérieux NutriSciences Corporation (France), ifp Institut für Produktqualität GmbH (Germany), ALS (Australia), Microbac Laboratories, Inc. (U.S.), FoodChain ID Group, Inc (U.S.), AsureQuality (New Zealand), Campden BRI (U.K.), ANGLE plc (U.K.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global pathogen detection market is segmented on the basis of type, consistency, culture media, contaminant type, total count, technology, customer type, application, end user, and distribution channel.
- On the basis of type, the global pathogen detection market is segmented into products, and services
- On the basis of consistency, the global pathogen detection market is segmented into solid media, and liquid media
- On the basis of culture media, the global pathogen detection market is segmented into chemical composition, and synthetic media
- On the basis of contaminant type, the global pathogen detection market is segmented into salmonella, E.coli, listeria, campylobacter, clostridium perfringens, pseudomonas, cronobacter, coliforms, legionella, and others
- On the basis of total count, the global pathogen detection market is segmented into spoiling organisms, yeast and moulds, and others
- On the basis of technology, the global pathogen detection market is segmented into rapid, traditional, and other molecular-based tests
- On the basis of customer type, the global pathogen detection market is segmented into service lab, industry, and governmental/non-profit organization
- On the basis of application, the global pathogen detection market is segmented into diagnostics, pathology, forensics, clinical research, and drug discovery
- On the basis of end user, the global pathogen detection market is segmented into pathology laboratories, diagnostic centers, hospitals, biotechnology companies, pharmaceutical companies, culture collection repositories, cooling towers, blood banks, and others
- On the basis of distribution channel, the global pathogen detection market is segmented into direct tender, and retail sales
Major Players
Data Bridge Market Research recognizes the following companies as the major global pathogen detection market players in global pathogen detection market are Intertek Group plc (U.K.), Eurofins Scientific (Luxembourg), Mérieux NutriSciences Corporation (France), ifp Institut für Produktqualität GmbH (Germany), ALS (Australia), Microbac Laboratories, Inc. (U.S.), FoodChain ID Group, Inc (U.S.), AsureQuality (New Zealand), Campden BRI (U.K.), ANGLE plc (U.K.)
Market Developments
- In November 2021, Philips reinforced its ultrasound solution for Radiology by incorporating enhanced imaging tools and features. This strategic upgrade aims to elevate workflow effectiveness and enhance diagnostic certainty for healthcare professionals. The additional capabilities contribute to a more comprehensive and precise diagnostic experience, aligning with Philips' commitment to advancing medical imaging technologies and improving the overall efficiency and accuracy of radiological examinations
- In January 2019, SGS SA inaugurated a cutting-edge laboratory in Glasgow, U.K., reinforcing its service capabilities and capacity. The facility offers advanced amenities, including testing cell banks and routine bulk harvest, catering to a spectrum of biotherapeutics such as gene therapies, monoclonal antibodies, vaccines, cell therapies, and recombinant protein-based organic medicines. This strategic expansion underscores SGS SA's commitment to meeting the growing demands of the pharmaceutical and biotechnology industries with state-of-the-art solutions for product development and quality assurance
Regional Analysis
Geographically, the countries covered in the global pathogen detection market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
As per Data Bridge Market Research analysis:
North America is the dominant region in the global pathogen detection market during the forecast period 2023-2030
North America dominates the global pathogen detection market, driven by substantial investments and robust demand for pathogen detection products and services, particularly in the U.S. The region's emphasis on cutting-edge technologies and stringent regulatory standards fuels market growth. High investment capacities and a proactive approach to public health challenges position North America at the forefront, fostering advancements in pathogen detection solutions to meet the escalating demand and ensure the region's leadership in this critical healthcare domain.
Asia-Pacific is estimated to be the fastest-growing region in the global pathogen detection market during the forecast period 2023-2030
Asia-Pacific is expected to dominate the global pathogen detection market, exhibiting the highest growth rate from 2023 to 2030. This ascendancy is fueled by a heightened concern for pathogen detection in the region. As awareness grows and healthcare priorities shift, the Asia-Pacific market is anticipated to play a pivotal role in shaping the trajectory of pathogen detection technologies, reflecting the region's commitment to advancing diagnostic capabilities and ensuring public health.
For more detailed information about the global pathogen detection market report, click here – https://www.databridgemarketresearch.com/es/reports/global-pathogen-detection-market
